ganaxolone
Commercial- Indications
- Status epilepticus, Tuberous sclerosis complex, CDKL5 deficiency disorder
Company intelligence / Profile preview
Marinus Pharmaceuticals
Radnor, Pennsylvania, United Statesmarinuspharma.com ↗
- Ownership
- Public · MRNS
- Development stage
- Commercial
01
Overview
Marinus Pharmaceuticals developed ZTALMY® (ganaxolone), an FDA-approved oral suspension for seizures associated with CDKL5 deficiency disorder. The company continues to advance ganaxolone in IV and oral formulations targeting additional seizure disorders such as status epilepticus and tuberous sclerosis complex. Recent clinical results include pivotal trials in refractory status epilepticus and tuberous sclerosis complex, with topline data readouts expected or recently announced. The acquisition by Immedica strengthens the global reach of these therapies.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- small molecules (notably neuroactive steroids)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Tenacia Biotechnology for CNS disorders development in China/Asia-Pacific regionSagard Healthcare Partners revenue interest financing agreement related to U.S. net sales of ganaxolone/ZTALMY®
04
Financials
- Market cap
- $30.4M
- Total revenue
- $8.5M
- Enterprise value
- $44.2M
Beyond the preview
Go deeper on Marinus Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Marinus Pharmaceuticals.